Age and Ageing · 2012 · 47 citations · 10 references
PharmacyCommunity HealthPharmacoeconomicsCost-effectiveness AnalysisCost-utility AnalysisFalls PreventionCommunity-based PreventionCost-effectiveness ComparisonEconomic EvaluationHealth Services EvaluationHealthcare Cost AnalysisPatient-reported Outcome MeasuresCommunity Health Service EvaluationCost-utility Analysis InputsEconomic Evaluation AppraisalHealth Economic ReviewIncremental Cost EstimationMethods Of Economic EvaluationQuality-adjusted Life Year ModelingQuality-adjusted Life Year Valuation
OBJECTIVE: we estimated the cost-effectiveness of a community falls prevention service compared with usual care from a National Health Service and personal social services perspective over the 12 month trial period. DESIGN: a cost-effectiveness and cost utility analysis alongside a randomised controlled trial SETTING: community. PARTICIPANTS: people over 60 years of age living at home or in residential care who had fallen and called an emergency ambulance but were not taken to hospital. INTERVENTIONS: referral to community fall prevention services or usual health and social care. MEASUREMENTS: incremental cost per fall prevented and incremental cost per Quality-Adjusted Life Years (QALYs) RESULTS: a total of 157 participants (82 interventions and 75 controls) were used to perform the economic evaluation. The mean difference in NHS and personal social service costs between the groups was £-1,551 per patient over 1 year (95% CI: £-5,932 to £2,829) comparing the intervention and control groups. The intervention patients experienced on average 5.34 fewer falls over 12 months (95% CI: -7.06 to -3.62). The mean difference in QALYs was 0.070 (95% CI: -0.010 to 0.150) in favour of the intervention group. CONCLUSION: the community falls prevention service was estimated to be cost-effective in this high-risk group. Current Controlled Trials ISRCTN67535605. (controlled-trials.com).
10
Modeling Valuations for EuroQol Health States
Paul Dolan · Medical Care · 1997 · 4.6K citations
Garry Barton, Andrew Briggs, Elisabeth Fenwick · Value in Health · 2008 · 296 citations